Daisuke Ban

Daisuke Ban

Auto-generated profile, based on publicly available information

Daisuke Ban

Department of Hepatobiliary and Pancreatic Surgery Institute of Science Tokyo Tokyo Japan

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 September 2014 in Journal of Hepato-Biliary-Pancreatic Sciences
Verified
Journal Article
Closed access
PDF file
DBDaisuke Ban
Daisuke Ban
MTMinoru Tanabe
Minoru Tanabe
HIHiromitsu Ito
Hiromitsu Ito
YOYuichiro Otsuka
Yuichiro Otsuka
HNHiroyuki Nitta
Hiroyuki Nitta
GWGo Wakabayashi
Go Wakabayashi

6 December 2021 in Journal of Hepato-Biliary-Pancreatic Sciences
Verified
Journal Article
Closed access
PDF file
GWGo Wakabayashi
Go Wakabayashi
DCDaniel Cherqui
Daniel Cherqui
DGDavid A. Geller
David A. Geller
MHMohammed Abu Hilal
Mohammed Abu Hilal
GBGiammauro Berardi
Giammauro Berardi
MYMasakazu Yamamoto
Masakazu Yamamoto

1 July 2012 in Gastroenterology
Verified
Journal Article
Closed access
PDF file
RARama Adikrisna
Rama Adikrisna
Shinji TanakaShinji Tanaka
Shinji Tanaka
SMShunsuke Muramatsu
Shunsuke Muramatsu
AAArihiro Aihara
Arihiro Aihara
DBDaisuke Ban
Daisuke Ban
SAShigeki Arii
Shigeki Arii

15 November 2021 in Journal of Hepato-Biliary-Pancreatic Sciences
Verified
Journal Article
Closed access
PDF file
NGNaoto Gotohda
Naoto Gotohda
DCDaniel Cherqui
Daniel Cherqui
DGDavid A. Geller
David A. Geller
MHMohammed Abu Hilal
Mohammed Abu Hilal
GBGiammauro Berardi
Giammauro Berardi
GWGo Wakabayashi
Go Wakabayashi

27 February 2013 in Hepatology
Verified
Journal Article
Open access
PDF file
SMShunsuke Muramatsu
Shunsuke Muramatsu
Shinji TanakaShinji Tanaka
Shinji Tanaka
KMKaoru Mogushi
Kaoru Mogushi
RARama Adikrisna
Rama Adikrisna
AAArihiro Aihara
Arihiro Aihara
SAShigeki Arii
Shigeki Arii
Hepatocellular carcinoma (HCC) is one of the most aggressive malignancies because of recurrence and/or metastasis even after curative resection. Emerging evidence suggests that tumor metastasis and recurrence might be driven by a small subpopulation of stemness cells, so-called cancer stem cells (CSCs). Previous investigations have revealed that glioma and breast CSCs exhibit intrinsically low proteasome activity and that breast CSCs also reportedly contain a lower reactive oxygen species (ROS) level than corresponding nontumorigenic cells. Here we visualized two stem cell features, low proteasome activity and low intracellular ROS, in HCC cells using two-color fluorescence activated cell sorting to isolate cells with stem cell features. These cells were then analyzed for their division behavior in normoxia and hypoxia, expression of stem cell markers, tumorigenicity, metastatic potential, specific gene expression signatures, and their clinical implications. A visualized small subpopulation of HCC cells demonstrated asymmetric divisions. Their remarkable tumorigenicity in nonobese diabetic/severe combined immunodeficient mice suggested the cancer initiation potential of these HCC CSCs. Comprehensive gene expression analysis revealed that chemokine-related genes were up-regulated in the CSCs subpopulation. Our identified HCC CSCs facilitated the migration of macrophages in vitro and demonstrated metastatic potential by way of recruitment of macrophages in vivo. In patients who undergo curative operation for HCC, the CSC-specific gene signature in the liver microenvironment significantly correlates with recurrence. Conclusion: Based on these findings, the stem cell feature monitoring system proposed here is a promising tool to analyze the in vivo significance of CSC microenvironments in human HCCs. (HEPATOLOGY 2013;)

14 January 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
HIHiromitsu Ito
Hiromitsu Ito
Shinji TanakaShinji Tanaka
Shinji Tanaka
YAYoshimitsu Akiyama
Yoshimitsu Akiyama
SSShu Shimada
Shu Shimada
RARama Adikrisna
Rama Adikrisna
MTMinoru Tanabe
Minoru Tanabe
Patients with pancreatic cancer typically develop tumor invasion and metastasis in the early stage. These malignant behaviors might be originated from cancer stem cells (CSCs), but the responsible target is less known about invisible CSCs especially for invasion and metastasis. We previously examined the proteasome activity of CSCs and constructed a real-time visualization system for human pancreatic CSCs. In the present study, we found that CSCs were highly metastatic and dominantly localized at the invading tumor margins in a liver metastasis model. Microarray and siRNA screening assays showed that doublecortin-like kinase 1 (DCLK1) was predominantly expressed with histone modification in pancreatic CSCs with invasive and metastatic potential. Overexpression of DCLK1 led to amoeboid morphology, which promotes the migration of pancreatic cancer cells. Knockdown of DCLK1 profoundly suppressed in vivo liver metastasis of pancreatic CSCs. Clinically, DCLK1 was overexpressed in the metastatic tumors in patients with pancreatic cancer. Our studies revealed that DCLK1 is essential for the invasive and metastatic properties of CSCs and may be a promising epigenetic and therapeutic target in human pancreatic cancer.